Journals / The Journal of Pediatric Research / 2019 / Cilt: 6 - Sayı: 3

Risk Factors of Bloodstream Infections Caused by Carbapenem-resistant Gram-negative Pathogens in Pediatric Critical Care Settings

Pages
180–185
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a conclusion, we have to enhance infection control programs and prevent patients from redundant antibiotic exposure.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Infections and sepsis are the leading causes of death in non-cardiac intensive care units (ICUs) and account for 40 percent of all ICU expenditures.
📊
Key Findings & Data:Data regarding bloodstream infections (BSIs) due to a carbapenem-resistant gram negative (CRGN) microorganisms in pediatric ICUs still remain limited.Materials and Methods: This study was conducted retrospectively in patients who were admitted to two pediatric critical care units between January 2011 and December 2017.
💡
Conclusion & Impact:As a conclusion, we have to enhance infection control programs and prevent patients from redundant antibiotic exposure.
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Özet

Aim: Infections and sepsis are the leading causes of death in non-cardiac intensive care units (ICUs) and account for 40 percent of all ICU expenditures. Data regarding bloodstream infections (BSIs) due to a carbapenem-resistant gram negative (CRGN) microorganisms in pediatric ICUs still remain limited.Materials and Methods: This study was conducted retrospectively in patients who were admitted to two pediatric critical care units between January 2011 and December 2017. Patients were assigned to two groups. Patients with BSI caused by a CRGN microorganism and infections were assigned to the BSI group and those other than BSI were assigned to the non-BSI group.Results: This study included 89 critically ill children with a mean age of 52.1 (±65.1) months. The requirements for invasive procedures including tracheostomy, Foley catheter and central venous catheter were not statistically different among the groups, p values were 0.159, 0.291 and 0.803, respectively. The majority of the patients admitted to pediatric intensive care unit were due to sepsis/septic shock in the BSI group (n=18, 58%) and in the non-BSI group, this figure was 37.9% (n=24). Prior third/fourth generation cephalosporin exposure was significantly more common in the BSI group (51.6% vs 15.5%, p<0.001), carbapenem exposure was not significantly different among the groups (35.5% vs 56.9%, p=0.054). Neutropenia (<500/mm3) and thrombocytopenia (150x103/mm3) were significantly more common in the BSI group (p=0.011 and p=0.010) and the C-reactive protein level was significantly higher (p=0.018). Crude and attributable mortality did not show any significance between the groups, p values were 0.578 and 0.955, respectively.Conclusion: CRGN infections are still a major cause of morbidity, mortality and healthcare associated infections. In this study, we evaluated patients with BSI due to a CRGN microorganism and compared them with other infection types. The risk factors and outcomes were similar except for prior cephalosporin exposure. As a conclusion, we have to enhance infection control programs and prevent patients from redundant antibiotic exposure.

🔖

Cite This Article

BAL, Z. Ş., DUYU, M., KAMİT, F., YAZICI, P., ANIL, A. B., ÇİFTDOĞAN, D. Y., YILMAZ, N., ÇİLLİ, F., KARAPINAR, B. (2019). Risk Factors of Bloodstream Infections Caused by Carbapenem-resistant Gram-negative Pathogens in Pediatric Critical Care Settings. The Journal of Pediatric Research, Cilt: 6 - Sayı: 3, 180–185. https://ajindex.com/articles/362788

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. MacVane SH. Antimicrobial resistance in the intensive care unit: A focus on Gram-negative bacterial infections. J Intensive Care Med 2017;32:25-37
  2. Fridkin SK, Welbel SF, Weinstein RA. Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am 1997;11:479-96
  3. Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323-9
  4. Logan LK. Carbapenem-resistant enterobacteriaceae: An emerging problem in children. Clin Infect Dis 2012;55:852-9
  5. Chiotos K, Han JH, Tamma PD. Carbapenem-rresistant enterobacteriaceae infections in children. Curr Infect Dis Rep 2016;18:2
  6. Siddiqui NU, Qamar FN, Jurair H, Haque A. Multi-drug resistant gram-negative infections and use of intravenous polymyxin B in critically ill children of developing country: Retrospective cohort study. BMC Infect Dis 2014;28;14:626
  7. Chiotos K, Tamma PD, Flett KB, et al. Multicenter study of the risk factors for colonization or infection with carbapenem-resistant enterobacteriaceae in children. Antimicrob Agents Chemother 2017:61
  8. Leclercq R, Cantón R, Brown DF, et al. EUCAST expert rules in antimicrobial susceptibility testing. ClinMicrobiol Infect 2013;19:141-60
  9. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-32
  10. Goldstein B, Giroir B, Randolph A. International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensusconference: definitions for sepsis and organ dysfunction in pediatrics.Pediatr Crit Care Med 2005;6:2-8
  11. Drew RJ, Turton JF, Hill RL, et al. Emergence of carbapenem-resistant enterobacteriaceae in a UK paediatric hospital. J Hosp Infect 2013;84:300-4
  12. Huang ST, Chiang MC, Kuo SC, et al. Risk factors and clinical outcomes of patients with carbapenem-resistant acinetobacter baumannii bacteremia. J Microbiol Immunol Infect 2012;45:356-62
  13. Routsi C, Pratikaki M, Platsouka E, et al. Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients. Intensive Care Med 2013;39:1253-61
  14. Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant enterobacteriaceae infections. Emerg Infect Dis 2014;20:1170-5
  15. Ozsurekci Y, Aykac K, Cengiz AB, et al. Bloodstream infections